2,994 results on '"Medical equipment and supplies industry -- Reports"'
Search Results
2. Medical Physics Unit Researchers Publish Findings in Applied Sciences (Patient-Specific Dosimetry Evaluations in Theranostics Software for Internal Radiotherapy)
3. Data on Biomarkers Described by Researchers at Medtronic (Cardiac sensing at a spinal cord stimulation lead: a promising on-device potential biomarker for pain and wellbeing)
4. Anika Therapeutics, Inc. Files SEC Form 8-K, Current Report: (Jul. 11, 2024)
5. Anika Therapeutics, Inc. Files SEC Form 8-K, Current Report: (May 28, 2024)
6. Anika Therapeutics, Inc. Files SEC Form 8-K, Current Report: (May 8, 2024)
7. Anika Therapeutics, Inc. Files SEC Form 8-K, Current Report: (Mar. 13, 2024)
8. Anika Therapeutics, Inc. Files SEC Form 8-K, Current Report: (Feb. 26, 2024)
9. AtriCure Releases 2023 ESG Report
10. Boston Scientific Corp. Files SEC Form 8-K, Current Report: (Oct. 23, 2024)
11. Resmed Inc. Files SEC Form 144/A, Report of Proposed Sale of Securities: (Oct. 11, 2024)
12. Resmed Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Oct. 11, 2024)
13. Owens & Minor Inc. Files SEC Form 8-K, Current Report: (Oct. 15, 2024)
14. Steris Plc Files SEC Form 8-K, Current Report: (Oct. 7, 2024)
15. Resmed Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Oct. 8, 2024)
16. Resmed Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Oct. 7, 2024)
17. Iridex Corp. Files SEC Form 8-K, Current Report: (Oct. 3, 2024)
18. Conmed Corp. Files SEC Form 8-K, Current Report: (Oct. 4, 2024)
19. Boston Scientific Corp. Files SEC Form 144, Report of Proposed Sale of Securities: (Oct. 7, 2024)
20. Baxter International Inc. Files SEC Form 8-K, Current Report: (Oct. 9, 2024)
21. Angiodynamics Inc. Files SEC Form 8-K, Current Report: (Oct. 3, 2024)
22. Skinvisible, Inc. Files SEC Form 8-K, Current Report: (Oct. 3, 2024)
23. Non Invasive Monitoring Systems Inc. Files SEC Form 8-K, Current Report: (Sept. 27, 2024)
24. Milestone Scientific Inc. Files SEC Form 8-K, Current Report: (Sept. 27, 2024)
25. Icu Medical Inc. Files SEC Form 8-K, Current Report: (Oct. 2, 2024)
26. Icu Medical Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Oct. 1, 2024)
27. Fonar Corp. Files SEC Form 8-K, Current Report: (Sept. 30, 2024)
28. Conmed Corp. Files SEC Form 8-K, Current Report: (Sept. 30, 2024)
29. Cytosorbents Corp. Files SEC Form 8-K, Current Report: (Oct. 1, 2024)
30. Boston Scientific Corp. Files SEC Form 144, Report of Proposed Sale of Securities: (Oct. 1, 2024)
31. Becton Dickinson & Co Files SEC Form 8-K, Current Report: (Oct. 2, 2024)
32. Baxter International Inc. Files SEC Form 8-K, Current Report: (Sept. 30, 2024)
33. Resmed Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Sept. 12, 2024)
34. Intuitive Surgical Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Sept. 12, 2024)
35. Intuitive Surgical Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Sept. 13, 2024)
36. Haemonetics Corp. Files SEC Form 8-K, Current Report: (Sept. 16, 2024)
37. Stryker Corp. Files SEC Form 144, Report of Proposed Sale of Securities: (Sept. 17, 2024)
38. Stryker Corp. Files SEC Form 144, Report of Proposed Sale of Securities: (Sept. 13, 2024)
39. Patterson Companies, Inc. Files SEC Form 8-K, Current Report: (Sept. 18, 2024)
40. Owens & Minor Inc. Files SEC Form 8-K, Current Report: (Sept. 16, 2024)
41. Hologic Inc. Files SEC Form 8-K, Current Report: (Sept. 13, 2024)
42. Dexcom Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Sept. 16, 2024)
43. Biolife Solutions Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Sept. 18, 2024)
44. Baxter International Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Sept. 16, 2024)
45. Baxter International Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Sept. 13, 2024)
46. Becton Dickinson & Co Files SEC Form 144, Report of Proposed Sale of Securities: (Sept. 16, 2024)
47. Anika Therapeutics, Inc. Files SEC Form 8-K, Current Report: (Nov. 2, 2023)
48. Anika Therapeutics, Inc. Files SEC Form 8-K, Current Report: (Sept. 21, 2023)
49. Researchers at Hiroshima University Have Reported New Data on Life Sciences (Selective Activation of Ppar Alpha Maintains Thermogenic Capacity of Beige Adipocytes)
50. Predictive Oncology Inc. Files SEC Form 8-K, Current Report: (Jul. 29, 2024)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.